Decoy Therapeutics Inc
(DCOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,576 | -12,543 | -31,608 | -12,768 | -7,352 |
| Depreciation Amortization | 4 | 10 | 7 | 19 | 18 |
| Accounts receivable | N/A | 1,481 | N/A | 2,246 | -3,856 |
| Accounts payable and accrued liabilities | 334 | -2,256 | 1,313 | -311 | -3 |
| Other Working Capital | 772 | -968 | 2,370 | 2,035 | -3,038 |
| Other Operating Activity | -60 | 1,430 | 10,324 | -1,421 | 3,920 |
| Operating Cash Flow | $-4,525 | $-12,846 | $-17,595 | $-10,200 | $-10,311 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -3 |
| Purchase Sale Intangibles | N/A | N/A | -1,500 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -1,500 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-1,500 | $N/A | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,527 | 6,921 | 1,987 | 28,773 | 18,668 |
| Other Financing Activity | -467 | -281 | 0 | -477 | -974 |
| Financing Cash Flow | $1,060 | $6,640 | $1,987 | $28,296 | $17,694 |
| Beginning Cash Position | 5,900 | 12,106 | 29,214 | 11,119 | 3,739 |
| End Cash Position | 2,435 | 5,900 | 12,106 | 29,214 | 11,119 |
| Net Cash Flow | $-3,465 | $-6,207 | $-17,108 | $18,096 | $7,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,525 | -12,846 | -17,595 | -10,200 | -10,311 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -3 |
| Free Cash Flow | -4,525 | -12,846 | -17,595 | -10,200 | -10,314 |